ArticlesEventsCliniciansPacientsResearchersGen TherapyRaziskaveCTGCTNICRodrigo Ortiz 8 April 2025 Event Date: 21 March 2025 do: 21 March 2025 • CTGCT’s Role in the GeneH Project: Accelerating Gene Therapy Innovations We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ... More
EventsPacientsBusiness ModelInvestmentCTGCTNICRodrigo Ortiz 13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 • Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry. More
EventsResearchersGLPGMPDrug DiscoveryLaboratoryResearchCTGCTNICGregor Cuzak 3 March 2025 Event Date: 10 February 2025 − Workshop Report: Introduction to 4D-Nucleofector Technology A hands-on workshop on 4D-Nucleofector technology provided insights into gene transfer using Lonza’s Core- and X units. Participants learned about nucleofection, optimized protocols, and best practices for efficient gene delivery in cell-based research. More
ArticlesPacientsATMPsCell therapyGen TherapyBusiness ModelEconomicsPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 February 2025 How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ... More
ArticlesCliniciansPacientsResearchersATMPsCell therapyResearchCTGCTNICRodrigo Ortiz 25 February 2025 Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ... More
ArticlesPacientsResearchersGen TherapyLaboratoryPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 January 2025 The research on combining cytokines with pyroptosis is gaining widespread media coverage Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week". More
Media ReleasesCliniciansPacientsResearchersATMPsEconomicsResearchCTGCTNICGregor Cuzak 22 January 2025 Slovenia Joins ERDERA to Advance Rare Disease Research and Collaboration CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA More
Media ReleasesPacientsResearchCTGCTNICRodrigo Ortiz 10 January 2025 Head of CTGCT research selected as breakthrough discovery by the national TV in Slovenia Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ... More
ArticlesCliniciansPacientsCell therapyGen TherapyLaboratoryPre ClinicalResearchCTGCTNICRodrigo Ortiz 7 January 2025 Combining cytokines and pyroptosis, a promising weapon against cancer A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ... More
ArticlesMedia ReleasesResearchersATMPsCell therapyGen TherapyResearchCharite BerlinCTGCTNICTUDUCLUMCUtrechtRodrigo Ortiz 6 December 2024 CTGCT’s Innovation Report on Gene and Cell Therapy We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ) More
ArticlesPacientsGen TherapyDrug DiscoveryLaboratoryResearchCTGCTNICRodrigo Ortiz 22 November 2024 MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways. More
EventsCliniciansPacientsResearchersInvestmentRaziskaveRegulationCharite BerlinCTGCTNICNICUCLUMCUtrechtRodrigo Ortiz 25 October 2024 Event Date: 16 October 2024 do: 19 October 2024 • Review of CTGCT Conference 2024 From the 16th of October 2024 to the 18th the Kemijski Inštitut hosted the 1st CTGCT Conference More